Difference between revisions of "Expand the Use of MAT/MAR in Correctional Facilities"

From SAFE Solutions
Jump to navigation Jump to search
 
(17 intermediate revisions by one other user not shown)
Line 2: Line 2:
=Introductory Paragraph=
=Introductory Paragraph=


 
Individuals with opioid use disorder have higher risk of being involved in the criminal legal system. <ref>https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-opioid-use-disorder-treated-in-criminal-justice-system</ref> Those who are incarcerated have very high risks of opioid overdose upon release. <ref> https://pubmed.ncbi.nlm.nih.gov/30024795/</ref> Individuals struggling with mental health and substance use disorders may revolve in and out of correctional facilities, especially if they have not received treatment and they are released back to the community where their substance use cycle may continue. Several prisons are working towards implementing Medication-Assisted Treatment (MAT) and Medication-Assisted Recovery (MAR). MAT is utilized as an intervention in a controlled, safe environment and  has been shown to reduce drug use, overdose, and mortality and recidivism rates. <ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref> <ref>https://pubmed.ncbi.nlm.nih.gov/29913516/</ref> <ref>https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2671411</ref>
Several prisons are working towards implementing Medication-Assisted Treatment (MAT) and Medication-Assisted Recovery (MAR). Individuals struggling with mental health and substance use disorders may revolve in and out of correctional facilities, especially if they have not received treatment and they are released back to the community where their substance use cycle may continue. MAT is utilized as an intervention in a controlled, safe environment and  has been shown to reduce drug use, overdose, and mortality and recidivism rates. <ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>


=Key Information=
=Key Information=
   
   
The opioid epidemic has become a national public health crisis with an increase in overdose and overdose deaths. Those in the criminal justice system are significantly impacted by this epidemic. A National Survey on Drug Use and Health indicated the odds of being involved in the criminal justice system increase for those using opioids. <ref>https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf</ref> Those in the criminal justice system who transition back into the community after incarceration have high rates of returning to the criminal justice system or of relapsing. MAT can assist those with substance use disorder and reduce the rate of relapse. The FDA and SAMSHA identify MAT medications as Methadone, Buprenorphine, or Naltrexone for use for treatment of individuals with opioid use disorders. MAT may also be used in conjunction with behavioral health therapy. Medication and counseling in jails and prisons can lower overdose deaths after release. Best practices surrounding MAT in correctional facilities emphasize the importance of support and buy-in from correctional facilities leadership, support staff and community.<ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
The opioid epidemic has become a national public health crisis with an increase in overdose and overdose deaths. Those in the criminal justice system are significantly impacted by this epidemic. A National Survey on Drug Use and Health indicated the odds of being involved in the criminal justice system increase for those using opioids. <ref>https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf</ref> Those in the criminal justice system who transition back into the community after incarceration have high rates of returning to the criminal justice system or of relapsing. MAT can assist those with substance use disorder and reduce the rate of relapse.  
 
The FDA and SAMSHA identify MAT medications as Methadone, Buprenorphine, or Naltrexone for use for treatment of individuals with opioid use disorders. MAT may also be used in conjunction with behavioral health therapy. Medication and counseling in jails and prisons can lower overdose deaths after release. Best practices surrounding MAT in correctional facilities emphasize the importance of support and buy-in from correctional facilities leadership, support staff and community.<ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
 
The National Council for Wellbeing lists criteria that have been applied by some correctional facilities to determine who should receive MAT:  <ref>https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/</ref>


Some criteria that have been applied by correctional facilities to determine who should receive MAT include:
*Individuals previously on MAT in the community prior to arrest
*Individuals previously on MAT in the community prior to arrest
*Individuals diagnosed with a moderate or severe OUD
*Individuals diagnosed with a moderate or severe OUD
Line 15: Line 17:
*Individuals who are within a few weeks of release to the community
*Individuals who are within a few weeks of release to the community
*The capacity of the correctional facility to deliver the resources needed
*The capacity of the correctional facility to deliver the resources needed
'''Why Implement MAT in Prisons?'''
*Individuals who are incarcerated have very high risks of opioid overdose upon release<ref> https://pubmed.ncbi.nlm.nih.gov/30024795/</ref>
*Individuals with opioid use disorder (OUD) have higher risk of being involved in the criminal legal system<ref>https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-opioid-use-disorder-treated-in-criminal-justice-system</ref>
'''Benefits'''
*Reduces return to use of illicit opioids <ref>https://pubmed.ncbi.nlm.nih.gov/29913516/</ref>
*Reduces risk of opioid overdose death
*Increases retention in treatment
*Reduces recidivism<ref>https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2671411</ref>
*Reduces risk of suicide during incarceration
*Legal imperative -Increasing judicial recognition that MOUD should be standard care in jails and failing to provide MOUD violates individuals’ rights <ref>https://www.aclu.org/press-releases/federal-judge-rules-jail-must-allow-access-medication-assisted-treatment</ref>


=Relevant Research=
=Relevant Research=
'''Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care''' <ref>https://pubmed.ncbi.nlm.nih.gov/26076211/</ref>
   
   
'''This article''' titled "Release from prison - A high risk of death for former inmates," documents the higher risk of overdose death post-release. <ref>https://pubmed.ncbi.nlm.nih.gov/17215533/</ref>  
'''This article''' titled "Release from prison - A high risk of death for former inmates," documents the higher risk of overdose death post-release. <ref>https://pubmed.ncbi.nlm.nih.gov/17215533/</ref>  


'''Pew Study Opioid Use Disorder Treatment in Jails and Prisons''' <ref>https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2020/04/opioid-use-disorder-treatment-in-jails-and-prisons</ref>
'''This literature review''' documents the effectiveness of MAT in prison and jail settings, including increased retention in treatment.
<ref>https://pubmed.ncbi.nlm.nih.gov/30797392/</ref>
 
'''This White Paper''' summarizes research on a variety of benefits of MAT in correctional facilities, such as reduced risk of suicide during incarceration. <ref>https://www.ncchc.org/wp-content/uploads/From_the_General_Public_to_Americas_Jails_-_MAT_Saves_Lives-_Indivior.pdf</ref>


=Impactful Federal, State, and Local Policies=
=Impactful Federal, State, and Local Policies=


'''Massachusetts passed Chapter 208, An Act for Prevention and Access to Appropriate Care and Treatment of Addiction, authorizing a four-year pilot administering all three FDA-approved medications to treat OUD'''<ref> https://malegislature.gov/Laws/SessionLaws/Acts/2018/Chapter208</ref>
'''Federal Rights.''' In a landmark decision, a federal judge ordered a county jail to provide a woman with access to MAT) for her opioid use disorder during her jail sentence. Thus, thee is now a legal imperative that is increasing judicial recognition that MAT should be standard care in jails and failing to provide it violates individuals’ rights. <ref>https://www.aclu.org/press-releases/federal-judge-rules-jail-must-allow-access-medication-assisted-treatment</ref>
   
   
'''Support Act for Patients and Community Act'''<ref> https://www.congress.gov/bill/115th-congress/house-bill/6</ref>
'''The SUPPORT Act for Patients and Community''' mandated Medicaid coverage for MAT. <ref> https://www.congress.gov/bill/115th-congress/house-bill/6</ref>


'''State Based Medicaid may provide funding for MAT''' ''Medicaid Coverage of Medication Assisted Treatment (MAT): A 50-state overview''<ref>https://www.ncsl.org/research/health/mat-opiate-50-state-table-medicaid.aspx</ref>
'''Massachusetts''' passed Chapter 208, An Act for Prevention and Access to Appropriate Care and Treatment of Addiction. This authorized a four-year pilot administering all three FDA-approved medications to treat opioid use disorder. <ref>https://malegislature.gov/Laws/SessionLaws/Acts/2018/Chapter208</ref>


'''Joint Public Correctional Policy on the Treatment of Opioid Use Disorders for Justice Involved Individuals''' <ref>https://www.asam.org/docs/default-source/public-policy-statements/2018-joint-public-correctional-policy-on-the-treatment-of-opioid-use-disorders-for-justice-involved-individuals.pdf?sfvrsn=26de41c2_2</ref>
'''The American Correctional Association (ACA) and the American Society of Addiction Medicine (ASAM)''' issued a joint policy statement on the treatment of opioid use disorders for justice involved individuals. <ref>https://www.asam.org/docs/default-source/public-policy-statements/2018-joint-public-correctional-policy-on-the-treatment-of-opioid-use-disorders-for-justice-involved-individuals.pdf?sfvrsn=26de41c2_2</ref> It delineates specific recommendations for the following four domains:
*Screening and Prevention
*Treatment, with several points on MAT
*Reentry and Community Supervision Considerations
*Education


=Available Tools and Resources=
=Available Tools and Resources=


'''Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings''' <ref>https://store.samhsa.gov/sites/default/files/d7/priv/pep19-matusecjs.pdf</ref>
'''SAMHSA''' has published a report titled "Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings."  <ref>https://store.samhsa.gov/sites/default/files/d7/priv/pep19-matusecjs.pdf</ref> and a guidance brief for states titled "MAT in the Criminal Justice System." <ref>https://store.samhsa.gov/sites/default/files/d7/priv/pep19-matbriefcjs_0.pdf</ref>
 
'''BJA''' manages the Residential Substance Abuse Treatment Program (RSAT) <ref>https://www.rsat-tta.com/</ref> which offers training and technical assistance to county and states and which has published the "Prison/Jail Medication-Assisted Treatment Manual." <ref>https://www.rsat-tta.com/Files/RSAT_Prison_Med_Treat_FINAL.pdf</ref> BJA has also published "Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals." <ref>https://www.cossup.org/Content/Documents/JailResources/Guidelines_for_Managing_Substance_Withdrawal_in_Jails_6-6-23_508.pdf</ref>
 
'''The National Council for Wellbeing''' has published a report titled "Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons - A Planning and Implementation Toolkit." <ref>https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/</ref>
   
   
'''Jail-based Medication-Assisted Treatment Promising Practices, Guidelines, and Resources for the Field''' <ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
'''The National Sheriffs Association published "Jail-based Medication-Assisted Treatment Promising Practices, Guidelines, and Resources for the Field."  <ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
 
'''Prison/Jail Medication-Assisted Treatment Manual''' <ref>https://www.rsat-tta.com/Files/RSAT_Prison_Med_Treat_FINAL.pdf</ref>
'''The National Conference of State Legislatures''' provides a 50-state index of Medicaid Coverage of MAT. <ref>https://www.ncsl.org/research/health/mat-opiate-50-state-table-medicaid.aspx</ref>


'''The Bureau of Justice Assistance RSAT TTA program''' offers training and technical assistance to county and states<ref>https://www.rsat-tta.com/</ref>
'''The Opioid Response Network''' has a resource page titled "Medications for Opioid Use Disorder (MOUD) in Corrections."  <ref>https://opioidresponsenetwork.org/MOUDCorrections.aspx</ref>


'''Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons- A Planning and Implementation Toolkit'''<ref>https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/</ref>
'''The Pennsylvania Department of Corrections''' has an extensive resource page on MAT. <ref>https://www.cor.pa.gov/About%20Us/Initiatives/Pages/Medication-Assisted-Treatment.aspx</ref>


'''Opioid Response Network- Medications for Opioid Use Disorder (MOUD) in Corrections''' <ref>https://opioidresponsenetwork.org/MOUDCorrections.aspx</ref>
'''SAFE Project''' has an additional wiki page titled "Expand Access to MAT." <ref>https://www.yoursafesolutions.us/wiki/Expand_Access_to_Medication-Assisted_Treatment_(MAT)</ref>


Your Safe Solutions also includes additional information on Medication-assisted Treatments (MAT). <ref>https://www.yoursafesolutions.us/wiki/Expand_Access_to_Medication-Assisted_Treatment_(MAT)</ref>
'''Findings from JCOIN's Massachusetts clinical Research Center''' In a 2023 study, JCOIN researchers Drs. Elizabeth Evans, Ekaterina Pivovarova, Thomas Stopka, Claudia Santelices, Warren Ferguson, and Peter Friedmann from the University of Massachusetts Amherst, the University of Massachusetts Chan Medical School, Baystate Health, and Tufts University outline key steps MOUD program treatment staff can implement in order to prevent diversion. The study also provides guidance to corrections and lawmakers as they consider establishing and expanding MOUD treatment in correctional settings." <ref>https://mcusercontent.com/a3c8fbb7be6f3cee9df95f0bf/files/8dad90e1-d0f9-2ebd-a7ec-f18826b128ac/Appendix_A.pdf</ref>


=Promising Practices=
=Promising Practices=
   
   
'''Jail-based Medication-Assisted Treatment Promising Practices, Guidelines, and Resources for the Field'''-Includes promising practices and specific states with case studies including KY, RI, MA, WA.<ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
'''Case studies''' from California, Kentucky, Massachusetts, Rhode Island, and Washington are highlighted in this report by the National Sheriffs Association. <ref>https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf</ref>
'''Prison/Jail Medication-Assisted Treatment Manual'''<ref>https://www.rsat-tta.com/Files/RSAT_Prison_Med_Treat_FINAL.pdf</ref> Includes Training and Technical Assistance
 
'''Pennsylvania Department of Corrections MAT'''<ref>https://www.cor.pa.gov/About%20Us/Initiatives/Pages/Medication-Assisted-Treatment.aspx</ref>


'''SAMSHA Medication Assisted Treatment for OUD in Criminal Justice Settings''' <ref>https://store.samhsa.gov/product/Use-of-Medication-Assisted-Treatment-for-Opioid-Use-Disorder-in-Criminal-Justice-Settings/PEP19-MATUSECJS</ref>
'''Pew Charitable Trusts''' published a study titled "Opioid Use Disorder Treatment in Jails and Prisons" that includes positive case studies in Colorado, Massachusetts, Pennsylvania, and Vermont. <ref>https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2020/04/opioid-use-disorder-treatment-in-jails-and-prisons</ref>


=Sources=
=Sources=

Latest revision as of 11:38, 12 March 2024

Introductory Paragraph

Individuals with opioid use disorder have higher risk of being involved in the criminal legal system. [1] Those who are incarcerated have very high risks of opioid overdose upon release. [2] Individuals struggling with mental health and substance use disorders may revolve in and out of correctional facilities, especially if they have not received treatment and they are released back to the community where their substance use cycle may continue. Several prisons are working towards implementing Medication-Assisted Treatment (MAT) and Medication-Assisted Recovery (MAR). MAT is utilized as an intervention in a controlled, safe environment and has been shown to reduce drug use, overdose, and mortality and recidivism rates. [3] [4] [5]

Key Information

The opioid epidemic has become a national public health crisis with an increase in overdose and overdose deaths. Those in the criminal justice system are significantly impacted by this epidemic. A National Survey on Drug Use and Health indicated the odds of being involved in the criminal justice system increase for those using opioids. [6] Those in the criminal justice system who transition back into the community after incarceration have high rates of returning to the criminal justice system or of relapsing. MAT can assist those with substance use disorder and reduce the rate of relapse.

The FDA and SAMSHA identify MAT medications as Methadone, Buprenorphine, or Naltrexone for use for treatment of individuals with opioid use disorders. MAT may also be used in conjunction with behavioral health therapy. Medication and counseling in jails and prisons can lower overdose deaths after release. Best practices surrounding MAT in correctional facilities emphasize the importance of support and buy-in from correctional facilities leadership, support staff and community.[7]

The National Council for Wellbeing lists criteria that have been applied by some correctional facilities to determine who should receive MAT: [8]

  • Individuals previously on MAT in the community prior to arrest
  • Individuals diagnosed with a moderate or severe OUD
  • Individuals identified in a validated risk assessment to be at the highest risk of return to use or overdose
  • Individuals who are within a few weeks of release to the community
  • The capacity of the correctional facility to deliver the resources needed

Relevant Research

This article titled "Release from prison - A high risk of death for former inmates," documents the higher risk of overdose death post-release. [9]

This literature review documents the effectiveness of MAT in prison and jail settings, including increased retention in treatment. [10]

This White Paper summarizes research on a variety of benefits of MAT in correctional facilities, such as reduced risk of suicide during incarceration. [11]

Impactful Federal, State, and Local Policies

Federal Rights. In a landmark decision, a federal judge ordered a county jail to provide a woman with access to MAT) for her opioid use disorder during her jail sentence. Thus, thee is now a legal imperative that is increasing judicial recognition that MAT should be standard care in jails and failing to provide it violates individuals’ rights. [12]

The SUPPORT Act for Patients and Community mandated Medicaid coverage for MAT. [13]

Massachusetts passed Chapter 208, An Act for Prevention and Access to Appropriate Care and Treatment of Addiction. This authorized a four-year pilot administering all three FDA-approved medications to treat opioid use disorder. [14]

The American Correctional Association (ACA) and the American Society of Addiction Medicine (ASAM) issued a joint policy statement on the treatment of opioid use disorders for justice involved individuals. [15] It delineates specific recommendations for the following four domains:

  • Screening and Prevention
  • Treatment, with several points on MAT
  • Reentry and Community Supervision Considerations
  • Education

Available Tools and Resources

SAMHSA has published a report titled "Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings." [16] and a guidance brief for states titled "MAT in the Criminal Justice System." [17]

BJA manages the Residential Substance Abuse Treatment Program (RSAT) [18] which offers training and technical assistance to county and states and which has published the "Prison/Jail Medication-Assisted Treatment Manual." [19] BJA has also published "Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals." [20]

The National Council for Wellbeing has published a report titled "Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons - A Planning and Implementation Toolkit." [21]

The National Sheriffs Association published "Jail-based Medication-Assisted Treatment Promising Practices, Guidelines, and Resources for the Field." [22]

The National Conference of State Legislatures provides a 50-state index of Medicaid Coverage of MAT. [23]

The Opioid Response Network has a resource page titled "Medications for Opioid Use Disorder (MOUD) in Corrections." [24]

The Pennsylvania Department of Corrections has an extensive resource page on MAT. [25]

SAFE Project has an additional wiki page titled "Expand Access to MAT." [26]

Findings from JCOIN's Massachusetts clinical Research Center In a 2023 study, JCOIN researchers Drs. Elizabeth Evans, Ekaterina Pivovarova, Thomas Stopka, Claudia Santelices, Warren Ferguson, and Peter Friedmann from the University of Massachusetts Amherst, the University of Massachusetts Chan Medical School, Baystate Health, and Tufts University outline key steps MOUD program treatment staff can implement in order to prevent diversion. The study also provides guidance to corrections and lawmakers as they consider establishing and expanding MOUD treatment in correctional settings." [27]

Promising Practices

Case studies from California, Kentucky, Massachusetts, Rhode Island, and Washington are highlighted in this report by the National Sheriffs Association. [28]

Pew Charitable Trusts published a study titled "Opioid Use Disorder Treatment in Jails and Prisons" that includes positive case studies in Colorado, Massachusetts, Pennsylvania, and Vermont. [29]

Sources

  1. ↑ https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-opioid-use-disorder-treated-in-criminal-justice-system
  2. ↑ https://pubmed.ncbi.nlm.nih.gov/30024795/
  3. ↑ https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
  4. ↑ https://pubmed.ncbi.nlm.nih.gov/29913516/
  5. ↑ https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2671411
  6. ↑ https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
  7. ↑ https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
  8. ↑ https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/
  9. ↑ https://pubmed.ncbi.nlm.nih.gov/17215533/
  10. ↑ https://pubmed.ncbi.nlm.nih.gov/30797392/
  11. ↑ https://www.ncchc.org/wp-content/uploads/From_the_General_Public_to_Americas_Jails_-_MAT_Saves_Lives-_Indivior.pdf
  12. ↑ https://www.aclu.org/press-releases/federal-judge-rules-jail-must-allow-access-medication-assisted-treatment
  13. ↑ https://www.congress.gov/bill/115th-congress/house-bill/6
  14. ↑ https://malegislature.gov/Laws/SessionLaws/Acts/2018/Chapter208
  15. ↑ https://www.asam.org/docs/default-source/public-policy-statements/2018-joint-public-correctional-policy-on-the-treatment-of-opioid-use-disorders-for-justice-involved-individuals.pdf?sfvrsn=26de41c2_2
  16. ↑ https://store.samhsa.gov/sites/default/files/d7/priv/pep19-matusecjs.pdf
  17. ↑ https://store.samhsa.gov/sites/default/files/d7/priv/pep19-matbriefcjs_0.pdf
  18. ↑ https://www.rsat-tta.com/
  19. ↑ https://www.rsat-tta.com/Files/RSAT_Prison_Med_Treat_FINAL.pdf
  20. ↑ https://www.cossup.org/Content/Documents/JailResources/Guidelines_for_Managing_Substance_Withdrawal_in_Jails_6-6-23_508.pdf
  21. ↑ https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/
  22. ↑ https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
  23. ↑ https://www.ncsl.org/research/health/mat-opiate-50-state-table-medicaid.aspx
  24. ↑ https://opioidresponsenetwork.org/MOUDCorrections.aspx
  25. ↑ https://www.cor.pa.gov/About%20Us/Initiatives/Pages/Medication-Assisted-Treatment.aspx
  26. ↑ https://www.yoursafesolutions.us/wiki/Expand_Access_to_Medication-Assisted_Treatment_(MAT)
  27. ↑ https://mcusercontent.com/a3c8fbb7be6f3cee9df95f0bf/files/8dad90e1-d0f9-2ebd-a7ec-f18826b128ac/Appendix_A.pdf
  28. ↑ https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
  29. ↑ https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2020/04/opioid-use-disorder-treatment-in-jails-and-prisons
Retrieved from "https://yoursafesolutions.us/mediawiki/index.php?title=Expand_the_Use_of_MAT/MAR_in_Correctional_Facilities&oldid=4896"